MDD and the COVID-19 pandemic: challenges and opportunities

Learning objectives

After this meeting, participants should be able to:

• Describe the neuropsychiatric consequences of COVID-19 and the impact of COVID-19 on the mental health of patients and healthcare professionals
• Describe the considerations for treatment selection in patients with MDD in light of the COVID-19 pandemic
• Discuss how overcoming the challenges of the COVID-19 pandemic may be driving positive change within psychiatric care

Chair:

• Siegfried Kasper (chair) and Allan Young (co-chair)